Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTB101 phase 3 study for prevention of respiratory illness in older adults
2019-002014-39Phase 3Terminated
- Sponsor
- resTORbio
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Airways Infection comparing RTB101 with Placebo (2 arms). Primary endpoint: Percentage of subjects with clinically symptomatic respiratory illness. Started Jul 2019; status: terminated.
02
Drugs
dactolisib
03
Conditions
Airways Infection
Beyond the preview
Go deeper on 2019-002014-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002014-39.